Dedong Wu is an associate principal scientist in Advance Drug Delivery at AstraZeneca. He provides expertise in the areas of drug substance form selection, enabling formulation, targeted drug delivery and predictive pharmaceutics. He has experiences for both early-stage drug candidate assessment and commercial drug product development. Dedong had worked in Bristol-Myers Squibb for 5 years before he joined Astrazeneca in 2005. He received his Ph.D. in physical chemistry and has published more than 80 scientific papers.